Catalent Celebrates 80 Years of Softgel Innovation at Interphex
Somerset, N.J. – March 17, 2014 — Celebrating 80 years of softgel innovation, Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that its senior management team, as well as graduates from the company’s Global Operations Leadership Development (GOLD) program, will present at the “Educational Programs for Young Professionals” day. The company will also present “Advanced Aseptic Processing to Reduce Risk with Sterile Fill/Finish” on the event’s Innovation Stage during the forthcoming Interphex trade show.
On Wednesday, March 19th, Sridhar Krishnan, Catalent’s Vice President, Global Operations, will present “Catalent GOLD - Accelerating Leadership Pipeline in Pharma & Biotech.” Catalent’s GOLD program is an intensive two-year leadership development opportunity, designed for university graduates who have a strong desire to accelerate their career growth in an entrepreneurial, fast-paced environment. Mr. Krishnan’s presentation, which takes place from 10.30-11.30 am, will outline the GOLD leadership model and will feature the first hand experiences of three graduates who have successfully participated in the program.
Also on Wednesday 19th, from 2.45 to 3.45 pm, Akan Oton, Catalent’s Director, Global Licensing & Corporate Alliances, will lead a discussion on “Commercializing Emerging Drug Delivery Technologies,” which takes place from 2:45 to 3:45 pm. His presentation will address the evolving role of drug delivery in pharma products from a commercial perspective and will look at current trends in drug delivery and unmet needs currently being pursued by innovators. He will also give examples of a typical path to commercialization of drug delivery technologies by innovators. On Thursday, March 20th, from 11.45 am to 12.45 pm, Bill Hartzel, Catalent’s Director, Strategic Execution, Advanced Delivery Technologies will present, “Advanced Aseptic Processing to Reduce Risk with Sterile Fill/Finish.” His presentation will feature ways to identify the Quality by Design elements of Blow/Fill/Seal equipment and the evaluation of the risk mitigation properties of advanced aseptic properties as well as taking a look at Catalent’s newly launched ADVASEPTTM technology.Interphex takes place from 18th to 20th March at the Javits Center, New York City, NY. To arrange a meeting with Catalent executives at the show, please contact Richard Kerns at NEPR - email@example.com. For further information on the “Educational Programs for Young Professionals” day and Interphex visit www.interphex.com
Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in Fiscal 2013 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com .